Daniel Esgardo Rangel Barón: FDA Recalls Some Valsartan Medicines Due to Impurity

Three companies are recalling several drug products containing valsartan due to the presence of N-nitrosodimethylamine, which is classified as a probable human carcinogen.
News Alerts
View Source

Related Post